Published in Stroke on December 01, 2000
Robot-assisted Hand Rehabilitation for Patients With Stroke | NCT03392493
Post-stroke Immunological Changes in Younger Stroke Patients | NCT03725137
Effects of Virtual Reality Game on Upper Extremity Function for Stroke | NCT04296032
Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial. Lancet Neurol (2008) 1.69
What are the determinants of quality of life in people with cervical dystonia? J Neurol Neurosurg Psychiatry (2002) 1.33
Assessment of vision-related quality of life in patients with homonymous visual field defects. Graefes Arch Clin Exp Ophthalmol (2007) 1.32
Positive effects of robotic exoskeleton training of upper limb reaching movements after stroke. J Neuroeng Rehabil (2012) 1.22
Virtual reality environments for post-stroke arm rehabilitation. J Neuroeng Rehabil (2007) 1.13
A community-based group exercise program for persons with chronic stroke. Med Sci Sports Exerc (2003) 1.12
Perceived wellbeing of patients one year post stroke in general practice--recommendations for quality aftercare. BMC Neurol (2011) 1.03
Determinants of participation restriction among community dwelling stroke survivors: a path analysis. BMC Neurol (2009) 1.03
Ischemic stroke incidence in Santa Coloma de Gramenet (ISISCOG), Spain. A community-based study. BMC Neurol (2008) 0.99
Functional, cognitive and psychological outcomes, and recurrent vascular events in Pakistani stroke survivors: a cross sectional study. BMC Res Notes (2012) 0.98
Health related quality of life of stroke survivors: experience of a stroke unit. Int J Biomed Sci (2012) 0.94
Post-stroke depression: prevalence and relationship with disability in chronic stroke survivors. Ann Indian Acad Neurol (2010) 0.93
Caregiver characteristics predict stroke survivor quality of life at 4 months and 1 year. Res Nurs Health (2009) 0.92
Determinants of quality of life in the acute stage following stroke. Psychiatry Investig (2012) 0.91
The correlates and course of depression in patients with lacunar stroke: results from the Secondary Prevention of Small Subcortical Strokes (SPS3) study. Cerebrovasc Dis (2011) 0.90
Confirmatory factor analysis of the validity of the SF-12 for persons with and without a history of stroke. Qual Life Res (2010) 0.89
Plasticity in the sensorimotor cortex induced by Music-supported therapy in stroke patients: a TMS study. Front Hum Neurosci (2013) 0.88
A cross-sectional study of quality of life in incident stroke survivors in rural northern Tanzania. J Neurol (2011) 0.87
Factors affecting the quality of life after ischemic stroke: young versus old patients. J Clin Neurol (2005) 0.87
Basal ganglia haematomas in non-comatose patients: subacute stereotactic aspiration improves long-term outcome in comparison to purely medical treatment. Neurosurg Rev (2004) 0.86
What determines the self-rated health of older individuals with stroke compared to other older individuals? A cross-sectional analysis of the Medical Research Council Cognitive Function and Aging Study. BMC Geriatr (2013) 0.86
Potential predictors for health-related quality of life in stroke patients undergoing inpatient rehabilitation. Health Qual Life Outcomes (2015) 0.86
Factors that Affect the Quality of Life at 3 Years Post-Stroke. J Clin Neurol (2006) 0.85
The burden of stroke in the Netherlands: estimating quality of life and costs for 1 year poststroke. BMJ Open (2015) 0.84
Kinematic analysis of the upper limb motor strategies in stroke patients as a tool towards advanced neurorehabilitation strategies: a preliminary study. Biomed Res Int (2014) 0.82
Health-related quality of life after ischemic stroke: the impact of pharmaceutical interventions on drug therapy (pharmaceutical care concept). Health Qual Life Outcomes (2010) 0.81
Exercise perceptions among people with stroke: Barriers and facilitators to participation. Int J Ther Rehabil (2011) 0.80
Functional, cognitive and emotional long-term outcome of patients with ischemic stroke requiring mechanical ventilation. J Neurol (2005) 0.80
Quality of life amongst young adults with stroke living in Kenya. Afr Health Sci (2013) 0.80
Exercise training and recreational activities to promote executive functions in chronic stroke: a proof-of-concept study. J Stroke Cerebrovasc Dis (2014) 0.80
Stroke Recovery: Surprising Influences and Residual Consequences. Adv Med (2015) 0.79
Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy. BMC Neurol (2012) 0.78
Quality of Life in Chronic Disease Patients. Health Psychol Res (2013) 0.78
Reliability and validity of the Nigerian (Hausa) version of the Stroke Impact Scale (SIS) 3.0 index. Biomed Res Int (2014) 0.77
Treatment of visuospatial neglect with biparietal tDCS and cognitive training: a single-case study. Front Syst Neurosci (2014) 0.77
Sensorimotor training and neural reorganization after stroke: a case series. J Neurol Phys Ther (2013) 0.77
Evaluation of the effects of the Arm Light Exoskeleton on movement execution and muscle activities: a pilot study on healthy subjects. J Neuroeng Rehabil (2016) 0.76
From rehabilitation to recovery: protocol for a randomised controlled trial evaluating a goal-based intervention to reduce depression and facilitate participation post-stroke. BMC Neurol (2011) 0.76
The Cognition and Affect after Stroke - a Prospective Evaluation of Risks (CASPER) study: rationale and design. BMC Neurol (2016) 0.76
Relationship Between Walking Capacity, Biopsychosocial Factors, Self-efficacy, and Walking Activity in Persons Poststroke. J Neurol Phys Ther (2016) 0.75
Minimal depression: how does it relate to upper-extremity impairment and function in stroke? Am J Occup Ther (2013) 0.75
Quality of life and associated factors among poststroke clinic attendees at a University Teaching Hospital in Nigeria. Niger Med J (2016) 0.75
Neuropsychiatric manifestation after a stroke: newly developed symptoms or side-effect of drug? BMJ Case Rep (2012) 0.75
Quality of life after stroke in Pakistan. BMC Neurol (2016) 0.75
Imaging Markers of Post-Stroke Depression and Apathy: a Systematic Review and Meta-Analysis. Neuropsychol Rev (2017) 0.75
Guidelines for the treatment of acute ischaemic stroke. Neurologia (2011) 2.05
[Endovascular treatment in acute ischaemic stroke. A stroke care plan for the region of Madrid]. Neurologia (2013) 1.97
Aberrant splicing of a mouse disabled homolog, mdab1, in the scrambler mouse. Neuron (1997) 1.49
[Direct cost of cerebrovascular disease during the first year of follow-up]. Rev Neurol (1999) 1.44
Failure of cefotaxime in the treatment of meningitis due to relatively resistant Streptococcus pneumoniae. Clin Infect Dis (1994) 1.44
[The psychometric properties of the Spanish version of the stroke-adapted 30-item Sickness Impact Profile (SIP30-AI)]. Rev Neurol (2007) 1.38
Middle cerebral artery embolism and unilateral visual loss after autologous fat injection into the glabellar area. Stroke (1993) 1.23
Randomized phase III study of 3-weekly versus weekly docetaxel in pretreated advanced non-small-cell lung cancer: a Spanish Lung Cancer Group trial. Ann Oncol (2005) 1.21
Risk of ischemic stroke and lifetime estrogen exposure. Neurology (2007) 1.09
Bihemispheric contribution to motor recovery after stroke: A longitudinal study with transcranial doppler ultrasonography. Cerebrovasc Dis (1999) 1.00
Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. Methods Find Exp Clin Pharmacol (1991) 0.97
Prediction of early stroke recurrence in transient ischemic attack patients from the PROMAPA study: a comparison of prognostic risk scores. Cerebrovasc Dis (2012) 0.95
Antibody response in dogs experimentally infected with Leishmania infantum: infection course antigen markers. Exp Parasitol (1996) 0.91
Alien hand sign or alien hand syndrome? J Neurol Neurosurg Psychiatry (1995) 0.91
The fertilizer value of pig slurry. I. Values depending on the type of operation. Bioresour Technol (2004) 0.89
Expressive writing and the role of alexythimia as a dispositional deficit in self-disclosure and psychological health. J Pers Soc Psychol (1999) 0.88
Guidelines for the preventive treatment of ischaemic stroke and TIA (II). Recommendations according to aetiological sub-type. Neurologia (2011) 0.88
Carotid body tumor: unusual cause of transient ischemic attacks. Stroke (1988) 0.88
Spontaneous cervical epidural hematoma with Brown-Séquard syndrome and spontaneous resolution. Case report. J Neurosurg Sci (1993) 0.87
Clinical practice guidelines in intracerebral haemorrhage. Neurologia (2011) 0.86
Combined effect of HLA-DRB1*1501 and interleukin-1 receptor antagonist gene allele 2 in susceptibility to relapsing/remitting multiple sclerosis. J Neuroimmunol (1997) 0.85
Characterization of DNA from differentiated cells. Analysis of the chicken genomic complexity. Eur J Biochem (1974) 0.84
Intestinal amyloidosis in hamsters with visceral leishmaniasis. Br J Exp Pathol (1986) 0.83
May intracranial hypotension be a cause of venous sinus thrombosis? Eur Neurol (2004) 0.82
[Pontine stroke secondary to a foramen magnum meningioma]. Rev Neurol (2005) 0.82
Study of the degradation of the herbicides 2,4-D and MCPA at different depths in contaminated agricultural soil. Environ Sci Technol (2001) 0.81
Sex differences in estrogenic regulation of preproenkephalin mRNA levels in the medial preoptic area of prepubertal rats. Brain Res Mol Brain Res (1998) 0.81
Improving postharvest resistance in fruits by external application of trans-resveratrol. J Agric Food Chem (2003) 0.80
Clinical management guidelines for subarachnoid haemorrhage. Diagnosis and treatment. Neurologia (2012) 0.80
[Right sensory-motor syndrome as the presentation of a spontaneous cervico-thoracic epidural hematoma]. Rev Neurol (1998) 0.80
[Stroke and intracranial stenosis: clinical profile in a series of 134 patients in Spain]. Rev Neurol (2004) 0.80
[Detection of viral genomes of the Herpesviridae family in multiple sclerosis patients by means of the polymerase chain reaction (PCR)]. Enferm Infecc Microbiol Clin (2000) 0.79
Guidelines for the preventive treatment of ischaemic stroke and TIA (I). Update on risk factors and life style. Neurologia (2011) 0.78
[Blood flow in patients with intracerebral hemorrhage. Does there exist the associated hypoperfusion? A transcranial Doppler study]. Rev Neurol (2000) 0.78
Frequency of CYP2D6 allelic variants in multiple sclerosis. Acta Neurol Scand (1995) 0.78
Effects of hydroxyl groups on nicotine-like activity and on size in solution. Arch Farmacol Toxicol (1987) 0.78
[Value of the transcranial Doppler examination in the diagnosis of brain death]. Med Clin (Barc) (1993) 0.78
[Pharmacological properties in vitro of various extracts of Mimosa tenuiflora (tepescohuite)]. Arch Invest Med (Mex) (1991) 0.78
Treatment of animal carcasses in poultry farms using sealed ditches. Bioresour Technol (2008) 0.78
Serum levels of nitrates in focal cerebral ischemia. Eur J Neurol (1995) 0.77
Long-term influence of anticonvulsant agents on calcitonin, parathyroid hormone and osteocalcin. Eur Neurol (1992) 0.77
Pharmacologic modulation of vascular permeability in ocular allergy in the rat. Invest Ophthalmol Vis Sci (1990) 0.77
[Effect produced by the alkaloid fraction of Mimosa tenuiflora (tepescohuite) on the peristaltic reflex of the guinea pig ileum]. Arch Invest Med (Mex) (1991) 0.77
[Genetics and Alzheimer's disease]. Neurologia (2009) 0.77
Assessment of service use patterns in out-patients with schizophrenia: a Spanish study. Acta Psychiatr Scand Suppl (2006) 0.77
Obtaining a protein concentrate from integral defatted sunflower flour. Bioresour Technol (2001) 0.76
[Dolichoectasia of multiple cranial arteries. Findings on neuroimaging and transcranial Doppler]. Rev Neurol (1997) 0.76
[Antioxidant enzymes in acute cerebral infarction]. Neurologia (2004) 0.75
Poststroke sexual dysfunction and quality of life. Stroke (1999) 0.75
[Lupus anticoagulant and recurrent transient ischemic attacks]. Neurologia (1990) 0.75
[Effect of DL-amphetamine sulfate on oxygen and glucose consumption and oxidative phosphorylation of rat liver in vitro]. Arch Farmacol Toxicol (1978) 0.75
[Calcification of the basal ganglia and hypoparathyroidism: Fahr disease. Study of a family]. Arch Neurobiol (Madr) (1990) 0.75
[Expanding extraparenchymal cerebral process with extrapyramidal symptomatology]. Rev Clin Esp (1975) 0.75
[Diagnosis of Moyamoya disease using magnetic resonance]. Neurologia (1991) 0.75
[Cerebral activation during movement of both hands. A study with transcranial Doppler]. Rev Neurol (2000) 0.75
[The role of the nurse in the care of the convalescente patient]. Rev Col Nac Enferm (1975) 0.75
[Effect of D-amphetamine and clonidine on adenosinetriphosphatase activity and associated oxygen consumption in the rat brain in vitro]. Arch Farmacol Toxicol (1982) 0.75
Acute encephalopathy following lumbar myelography with iohexol. Acta Neurol (Napoli) (1992) 0.75
Long-term influence of levodopa on bone mass and growth hormone in postmenopausal women with Parkinson's disease. Clin Neuropharmacol (1987) 0.75
[The stroke unit a the Clinical Hospital in Madrid]. Rev Neurol (1996) 0.75
[Isolated hypoglossal nerve palsy as a manifestation of carotid artery dissection. Letter]. Rev Neurol (1997) 0.75
[The one and a half vertical syndrome as the only evidence of bilateral thalamo-subthalamic infarction]. Rev Neurol (1998) 0.75
[Management of cerebral infarction in the acute phase. Ad hoc Editorial Committee of the Task Force on Cerebrovascular Diseases of SEN]. Neurologia (1998) 0.75
[Cerebrovascular manifestations of gastrointestinal diseases]. Rev Neurol (1995) 0.75
[Correlation between bronchofibroscopy and cytology]. Rev Chil Obstet Ginecol (1978) 0.75
[Spontaneous intrapetrous dissection of the internal carotid in muscular fibrodysplasia]. Neurologia (1993) 0.75
[Multiple sclerosis. Its permanent identity crisis]. Rev Clin Esp (1988) 0.75
False positive of ADA determination in cerebrospinal fluid. Acta Neurol (Napoli) (1994) 0.75
[Results of tuberculosis surveys in Santiago de Chile]. Rev Med Chil (1973) 0.75
[Effect of 5-hydroxytryptophan and its derivatives l-glutamate and alfa ketoglutarate on oxygen and glucose uptake by rat brain tissue "in vitro" (author's transl)]. Arch Farmacol Toxicol (1977) 0.75
Magnetic resonance imaging of acute spontaneous dissection of the vertebral artery. Stroke (1991) 0.75
["Trombolisis" or "trombólisis"]. Rev Neurol (1998) 0.75
[Treatment with the immunosuppressive agents methotrexate and chlorambucil of patients with progessive chronic polyarthritis]. Rev Esp Reum Enferm Osteoartic (1972) 0.75
[Type A adenocarcinoma grafted into C3H/he mice subjected to treatment with various antineoplastic agents. II. Histopathological and ultrastructural study]. Rev Esp Oncol (1983) 0.75
[Effects of alpha and beta adrenergic agonists on oxygen uptake in rat brain "in vitro"(author's transl)]. Arch Farmacol Toxicol (1981) 0.75
[Thrombolysis in Madrid: is there improvement in the 4 years temporal analysis?]. Neurologia (2009) 0.75
[Effect of dibenzepin hydrochloride on oxygen and glucose consumption and oxidative phosphorylation of rat brain in vitro]. Arch Farmacol Toxicol (1978) 0.75
[Candida albicans meningitis in 2 parenteral drug addicts. Review of the literature]. Enferm Infecc Microbiol Clin (1993) 0.75
[Stroke in a young patient with the ascending pharyngeal artery mimicking dissection of carotid artery]. Rev Neurol (2005) 0.75
[Effect of adrenergic alpha agonists and dopaminergic agents on the oxidative activity of the rat brain in vitro]. Arch Farmacol Toxicol (1982) 0.75
[Perception of long term overload in care-givers of patients who have survived a stroke]. Rev Neurol (1999) 0.75
[Effect of D-L amphetamine sulphate on the oxygen and glucose uptake and oxidative phosphorylation of rat brain "in vitro" (author's transl)]. Arch Farmacol Toxicol (1977) 0.75
[Post stroke depression: predictive factors at one year follow up]. Rev Neurol (2002) 0.75
[Effect of viloxazine hydrochloride on cerebral oxidative metabolism in the rat in vitro]. Arch Neurobiol (Madr) (1983) 0.75
Peripheral iron metabolism in patients with focal cerebral ischemia. Eur J Neurol (1995) 0.75
[Effect of etomidate on the oxidative metabolism and ATPase activity of the rat brain in vitro]. Arch Farmacol Toxicol (1982) 0.75
Acetylator polymorphism in multiple sclerosis. Acta Neurol Scand (1994) 0.75
[Description of a case of laterocaudal bulbar syndrome (contribution to the semiological study of Wallenberg's and Opalski's syndromes)]. Rev Clin Esp (1973) 0.75
[Neurovascular intervention in the acute phase of cerebral infarction]. Neurologia (2010) 0.75
[The small intestine in malnutrition]. Gac Med Mex (1966) 0.75
[Paramedian thalamo-mesencephalic infarct con triphasic waves]. Neurologia (1996) 0.75
[Oculocerebral syndrome: an infrequent pathological manifestation of carotid occlusion]. Rev Neurol (1998) 0.75
[Comparative analysis of trazodone and imipramine against acetylcholine and electrical stimulation in the isolated guinea pig ileum]. Arch Farmacol Toxicol (1983) 0.75
[Stroke management: between the desirable and the indispensable]. An Med Interna (1995) 0.75
How predictors and patterns of stroke recurrence after a TIA differ during the first year of follow-up. J Neurol (2014) 0.75
[Effect of pimozide on the oxygen and glucose uptake of rat brain "in vitro" (author's transl)]. Arch Farmacol Toxicol (1979) 0.75
[A sensation of obstruction in the nasal cavity due to trigeminal nucleus involvement]. Rev Neurol (1998) 0.75
[Complicated migraine: a study of 7 cases]. Neurologia (1990) 0.75